The development of cell microencapsulation systems began several decades ago. However,
today few systems have been tested in clinical trials. For this reason, in the last years …

Encapsulated beta cell transplantation offers a potential cure for a subset of diabetic
patients. Once transplanted, beta cell grafts can help to restore glycemic control; however …

Brain abscess is a life-threatening condition that requires a timely and accurate diagnosis. In
this study, linezolid, an oxazolidinone antibiotic, was labeled with technetium-99m according …

Brain cancer is a challenging disease to treat using conventional approaches. The present
investigation aimed to develop a radiopharmaceutical targeting brain cancer based on …

Purpose The present investigation aims to develop and evaluate a radiopharmaceutical for
targeting and assessing β-cells mass based on gliclazide, an antidiabetic drug that …

In this study, 99mTc–plazomicin, a new radio‐antibiotic complex, was prepared specifically
for bacterial infection localization and monitoring. Factors affecting the labeling reaction …

Aiming to develop specific diagnostic tool for invasive fungal infection, a
radiopharmaceutical based on anidulafungin was investigated. A two-step approach was …

Synaptic trafficking of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors
(AMPARs) is thought to cause excitotoxicity brain ischemia. However, given the current …

Acetaminosalol labeling reaction with technetium‐99m was optimized, and the
radiocomplex was obtained in a high radiochemical yield of 98.9±0.6% and high stability (> …

Abstract [99mTc] fonturacetam hydrazide was radiosynthesized to assess neuropsychiatric
disorders by targeting the brain. The nootropic drug was labeled with technetium-99m, and …